BmK AS: Scorpion Venom Peptide Effects on Epilepsy Seizures

A research paper details the anticonvulsant effects of scorpion venom peptide BmK AS. The study includes mortality rates, seizure duration reductions, and electrophysiological data from kainic acid and PTZ-induced mouse models. The document was authored by Lu Zhao and uploaded to figshare in April 2026.

Use Cases

• Analyze the dual therapeutic mechanism of Nav1.6 modulation and inflammasome inhibition based on the described electrophysiological and behavioral results.
• Validate neuroprotective effects in chronic epilepsy models based on the reported reduction in neuronal hyperexcitability and pyroptosis.
• Compare seizure parameter outcomes (mortality, duration, frequency) between treatment and control groups based on the provided percentages.
• Investigate the relationship between sodium channel subtype inhibition and cognitive/psychiatric improvement based on the described reversal of memory deficits and anxiety-like behaviors.

Strengths

• Includes specific quantitative results: mortality reduced to 0%, seizure duration reduced by 10.5%, severe seizure frequency reduced by 68.8%.
• Describes a clear dual mechanism of action: modulation of Nav1.6 sodium channels and inhibition of the NLRP1 inflammasome pathway.
• Results are derived from multiple experimental models: kainic acid-induced chronic epilepsy and PTZ-induced seizure models.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The primary data format is a DOCX document, which may require extraction for structured analysis.

Provenance

Source

figshare

Collection Method

Experimental research involving mouse models and electrophysiological studies.

Freshness

Last updated 2026-04-15 05:47:39; freshness should be verified.